Contact this trialFirst, we need to learn more about you.
Device
Lixelle® for Dialysis Amyloidosis
Recruiting1 award5 criteria
New York, New York
This trial tests Lixelle®, a special filter used during dialysis to remove a harmful protein from the blood, in patients with dialysis-related amyloidosis. The goal is to see if Lixelle® is safe and effective in reducing symptoms and improving quality of life for these patients. Lixelle® has been used in Japan for many years to treat this condition.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service